 KemPharm Inc NASDAQ: KMPH has selected KP1077 for idiopathic hypersomnia IH as its lead serdexmethylphenidate SDX candidate in the pipeline. Idiopathic hypersomnia is an uncommon sleep disorder resulting in chronic excessive daytime sleepiness. 